Crum Brian T has filed 36 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 33457 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 33457 | $0.00 | 0.0000 | 365,780,799 | 100.00% | 0.01% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 105019 | $1.47 | 428,802.0000 | 365,780,799 | 19.67% | 0.03% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 170163 | $0.00 | 533,821.0000 | 365,780,799 | 46.79% | 0.05% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 69386 | $0.00 | 330,201.0000 | 365,780,799 | 26.60% | 0.02% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 33457 | $0.00 | 363,658.0000 | 365,780,799 | 10.13% | 0.01% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 170163 | $0.00 | 340,327.0000 | 365,780,799 | 33.33% | 0.05% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 69386 | $0.00 | 69,387.0000 | 365,780,799 | 50.00% | 0.02% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 449560 | $0.00 | 449,560.0000 | 365,780,799 | 9999.99% | 0.12% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 299710 | $0.00 | 299,710.0000 | 365,780,799 | 9999.99% | 0.08% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 26097 | $0.00 | 203,594.0000 | 363,020,303 | 14.70% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 33456 | $0.00 | 237,050.0000 | 363,020,303 | 16.43% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 69387 | $0.00 | 306,437.0000 | 363,020,303 | 29.27% | 0.02% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 45622 | $0.67 | 260,815.0000 | 363,020,303 | 14.89% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 26097 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 33456 | $0.00 | 33,457.0000 | 363,020,303 | 50.00% | 0.01% |
| Feb. 28, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 69387 | $0.00 | 138,773.0000 | 363,020,303 | 33.33% | 0.02% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 510490 | $0.00 | 510,490.0000 | 363,020,303 | 9999.99% | 0.14% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 765730 | $0.00 | 765,730.0000 | 363,020,303 | 9999.99% | 0.21% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 8750 | $0.00 | 143,548.0000 | 0 | 6.49% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 26096 | $0.00 | 169,644.0000 | 0 | 18.18% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 33457 | $0.00 | 203,101.0000 | 0 | 19.72% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 25604 | $2.62 | 177,497.0000 | 0 | 12.61% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 26096 | $0.00 | 26,097.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 8750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 33457 | $0.00 | 66,913.0000 | 0 | 33.33% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 208160 | $0.00 | 208,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 208160 | $0.00 | 208,160.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 21030 | $0.00 | 120,488.0000 | 0 | 21.14% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 26097 | $0.00 | 155,335.0000 | 0 | 20.19% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Common Stock | 8750 | $0.00 | 129,238.0000 | 0 | 7.26% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 26097 | $0.00 | 52,193.0000 | 0 | 33.33% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 8750 | $0.00 | 8,750.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | M | Restricted Stock Units | 21030 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | F | Common Stock | 20537 | $2.17 | 134,798.0000 | 0 | 13.22% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Restricted Stock Units | 100370 | $0.00 | 100,370.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Crum Brian T | SVP, General Counsel & Secr. | A | Stock Option (Right to Buy) | 301100 | $0.00 | 301,100.0000 | 0 | 9999.99% | 0.00% |